Coapt Systems Launches Endotine Ribbon.

Second in a Series of Minimally Invasive Product Offerings

PALO ALTO, Calif. -- Coapt Systems, Inc., developer of bioabsorbable implants for the fixation of soft tissue in the plastic and reconstructive surgery markets, announced today that it released the Endotine Ribbon for commercial sale in the U.S. market at the American Association of Facial Plastic and Reconstructive Surgery congress held in Toronto, Canada on September 14-17.

"This is the second in a series of minimally invasive products that we plan to introduce. This product will enable us to address the needs of patients who desire the benefits of a jowl or neck lift without undergoing an extensive or highly invasive procedure. While the Ribbon can be employed in conventional facelift procedures, we believe many patients are searching for an option that can be combined with tiny incision approaches," said John Kraczkowsky, Senior Vice President, Sales and Marketing. "Currently, there are few options that are minimally invasive and that truly deliver lasting results like those seen with a Ribbon Lift."

According to the American Society of Aesthetic and Plastic Surgery (ASAPS), over 200,000 facelift procedures were performed in the U.S. in 2005. The Ribbon Lift is highly desirable for patients who seek lower facial rejuvenation without significant downtime. According to Dr. David Apfelberg, Medical Director for Coapt Systems, "Patients who desire refinement to previous open facelifts are excellent candidates for a minimally invasive Ribbon Lift."

Dr. Miles Graivier, who presented from the podium on early results with the Ribbon device at the prestigious Baker Gordon Plastic Surgery Symposium in February, states, "The Ribbon is highly versatile in a number of surgical approaches and procedures. I am achieving results in jowl and neck sculpting that I have not seen with other minimally invasive methods."

Endotine Ribbon is now available throughout the U.S.

About Coapt Systems

Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation based upon its patented MultiPoint Technology (MPT[TM]) platform. Coapt's product lineup includes the ENDOTINE Forehead, Midface-ST, Midface-B, TransBleph and Triple devices, all of which are FDA approved. The company released SurgiWire Incisionless Dissector for minimally invasive wrinkle release in February of 2006. The Company is also developing products for hand tendon repair and other non-invasive facial rejuvenation. Coapt Systems, Inc. is a privately held, venture-backed firm located in Palo Alto, California.

For further information, visit www.coaptsystems.com.